Kamis, 11 Juni 2026 - 22:06 WIB

Find and Follow Us

Global Markets

IHSG 5,886.03 -0.28%

S&P 500 7,270.89 +0.05%

NASDAQ 25,186.95 +0.07%

Dow Jones 50,124.97 +0.41%

FTSE 100 10,340.86 +0.84%

CAC 40 8,222.69 +0.75%

Nikkei 225 64,217.27 +0.06%

Hang Seng 24,249.29 -0.65%

Shanghai 3,987.01 -0.16%

KOSPI 7,763.95 +0.43%

STI 4,988.10 +0.59%

ASX 200 8,633.20 -0.23%

Sensex 73,832.55 -0.20%

Gold 4,098.70 -0.23%

Silver 64.19 -0.64%

Oil (WTI) 90.10 +0.08%

Brent 92.73 -0.40%

Copper 6.27 +0.35%

Gas Alam 3.07 -3.49%

Bitcoin 62,621.02 +1.91%

Ethereum 1,640.96 +1.29%

USD/IDR 17,977.00 -0.30%

EUR/USD 1.15 -0.12%

Advertisement

Milan Paleja - General Manager Pharma, President Director, Novartis Group Indonesia

Novartis Hadirkan Pengobatan Baru untuk Psoriasis dengan Secukinumab

Redaksi • 17 Agustus 2017

Latest Updates

- Advertisement -

Milan Paleja - General Manager Pharma, President Director, Novartis Group Indonesia

08:49 WIB • 17 Agustus 2017

Novartis Hadirkan Pengobatan Baru untuk Psoriasis dengan Secukinumab

Novartis Indonesia meluncurkan secukinumab, pengobatan baru bagi pasien psoriasis di Indonesia untuk mendapatkan kondisi…